Cedric Bogaert | Chief Executive Officer
myNEO Therapeutics

Cedric Bogaert cofounded myNEO, whose software uses neural networks trained on biological datasets to figure out the best personalized cancer immunotherapies for a given patient. myNEO focuses on neoantigen targets it identifies from the genomic profile of the tumor sample. Based on promising preclinical studies the Belgium-based startup has entered into partnerships with several pharma companies, including a program with CureVac to develop novel mRNA cancer vaccines.